What Are Exosomes and PDRN in Complexion Products?

While experimental makeup aesthetics dominate social discourse, a separate technical trend is emerging in complexion science: the incorporation of exosomes and polydeoxyribonucleotide (PDRN) into foundation formulations. Searches for "what are exosomes" increased 81% according to Cult Beauty data, with PDRN expanding from clinical settings into K-beauty serums and complexion products. Understanding these bioactive ingredients helps consumers evaluate the "skinification" of foundation beyond basic hydration claims, while enabling beauty brands to navigate the regulatory and formulation challenges of incorporating clinical-grade actives into color cosmetics.

Exosomes are extracellular vesicles that facilitate cell-to-cell communication and have demonstrated potential for skin regeneration and anti-aging applications. According to Total Dermatology, these nano-sized vesicles measure between 30 and 150 nanometers and transport proteins, lipids, and nucleic acids that contribute to maintaining skin health and fostering regeneration. In complexion products, exosome-infused foundations claim to deliver growth factors and signaling molecules that support skin barrier function while providing coverage.

The technology has migrated from professional dermatological treatments into consumer-facing products. NBC News reports that exosomes facilitate cell-to-cell communication, delivering instructions to other cells to help calm inflammation, repair damaged tissue, and increase collagen and elastin production. This mechanism has made exosomes particularly attractive for "skinification" formulations where foundation functions as both cosmetic coverage and active skincare treatment. Additionally, Irish Examiner notes that searches for exosome-related products increased 81% according to Cult Beauty data, indicating heightened consumer interest in bioactive complexion ingredients.

Polydeoxyribonucleotide (PDRN) consists of DNA fragments derived from salmon sperm that promote tissue repair and collagen synthesis. Originally used in clinical injectables, PDRN is now appearing in K-beauty complexion formulations marketed toward mature skin and post-procedure coverage. According to WWD, PDRN has emerged as skin care's latest prominent ingredient, making its way into everything from medical-grade treatments to topical serums and beyond.

The ingredient's clinical heritage provides significant marketing appeal. ScienceDirect confirms that PDRN consists of DNA fragments with molecular weights ranging from 50 to 1,500 kDa, mainly extracted from salmon trout or chum salmon sperm cells. Research demonstrates that PDRN promotes angiogenesis, cellular activity, collagen synthesis, and soft tissue regeneration through activation of adenosine A2A receptors. Rousso Adams Facial Plastic Surgery explains that PDRN activates the body's adenosine A2A receptors, encouraging fibroblasts to proliferate and work more efficiently, supporting stronger, healthier tissue formation.

These ingredients represent the next wave of "skinification," where foundation functions as both cosmetic coverage and active skincare treatment, moving beyond simple hydration to cellular-level skin support. Evoke.ie reports that searches for "PDRN skincare" are up 700% year-over-year, while "beta glucan skincare" has risen 181%, indicating broader consumer interest in bioactive complexion ingredients.

While these ingredients show promise in dedicated skincare, their efficacy in rinse-off or daily-wear foundation formats remains under investigation. According to NBC News, exosomes are typically found in serums because they penetrate deeper into the skin and are more stable in low-water, minimal-ingredient formulas. While they appear in moisturizers and creams, these formulations may weaken their effects due to the presence of emulsifiers and preservatives.

The concentration of actives required for cellular effects may exceed what can be stably formulated in pigmented emulsions. Foundation formulations must balance coverage, texture, and stability with active ingredient delivery, creating formulation challenges that dedicated skincare products do not face. Additionally, the regulatory landscape for exosomes and PDRN in cosmetics remains evolving, with dermatology clinics currently offering these ingredients in professional settings while consumer product efficacy continues to develop.

For consumers seeking custom formulations that incorporate specific bioactive ingredients at therapeutic levels based on individual skin concerns, Chromara notes that precision dispensing platforms enable personalized foundation that can accommodate specific actives like exosomes and PDRN based on individual skin profiles and concerns.